Palleon Co-Founder Awarded Nobel Prize in Chemistry

Posted by ISPE Boston
On October 7, 2022

Palleon Pharmaceuticals scientific co-founder Carolyn Bertozzi, Ph.D., has been awarded the 2022 Nobel Prize in Chemistry. Waltham-based Palleon is a clinical-stage company pioneering glyco-immunology drug development to treat cancer and inflammatory diseases. The award reflects Dr. Bertozzi’s deep contributions not only to chemistry but to biology and medicine, including the foundational science underlying Palleon’s first-in-class, […]

FDA Approves Amylyx Drug to Treat ALS

Posted by ISPE Boston
On October 7, 2022

Cambridge-based Amylyx Pharmaceuticals has won FDA approval for Relyvrio for the treatment of amyotrophic lateral sclerosis (ALS) also known as Lou Gehrig’s disease. Relyvrio significantly slowed the loss of physical function in people living with ALS in a randomized, placebo-controlled clinical trial. Relyvrio can be taken as a monotherapy or with existing approved treatments. ALS is […]

Biogen and Eisai Alzheimer’s Drug Shows Positive Results in Phase 3 Trial

Posted by ISPE Boston
On October 6, 2022

Partners Eisai and Biogen announced positive topline results from Eisai’s Phase 3 clinical trial of lecanemab, an investigational drug for the treatment of mild cognitive impairment (MCI) due to Alzheimer’s disease. Lecanemab met the primary endpoint and all key secondary endpoints with highly statistically significant results. Eisai plans to discuss the data with regulatory authorities […]

Chapter Member Anniversaries: October 2022

Posted by ISPE Boston
On October 6, 2022

Please congratulate the following members celebrating milestone anniversaries in October 2022. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Mark Caswell, Lonza Biologics Inc Louis Cicchese, Moderna Therapeutics William Devine, Pharma-Tech Services Peter Falk , Pharmaron Ric Feldt, Jeff Smith & Associates Michael Ku, Pfizer Inc William […]

Welcome New Members September 2022!

Posted by ISPE Boston
On October 6, 2022

We would like to introduce the Members who joined ISPE in September 2022, welcome them to the Chapter and encourage them (and all our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And the […]

3 Takeaways from ISPE Boston’s 2022 Product Show

Posted by Laura Berberian
On September 29, 2022

With the annual ISPE Boston Product Show behind us, the Product Show Committee chairs (Victor Taubinger and Laura Berberian) want to take a minute to reflect on some of the highlight’s from this year’s show: 1. Most well attended show ~ The Product Show opened for registration in early August and attendees started rolling in. […]

Pretzel Therapeutics Launches to Pioneer Mitochondrial Therapies

Posted by ISPE Boston
On September 22, 2022

Pretzel Therapeutics has launched with a $72.5 million Series A financing to pioneer novel therapies to modulate mitochondrial function. “We are excited to pioneer a new era in the treatment of diseases related to mitochondrial dysfunction. The expertise we have assembled and the platform technologies we have created will allow new inroads into treating both […]

Photys Therapeutics Debuts

Posted by ISPE Boston
On September 22, 2022

Founded by Longwood Fund and Dr. Amit Choudhary of Brigham and Women’s Hospital and the Broad Institute of MIT and Harvard, Cambridge-based Photys Therapeutics has launched with $75 million Series A funding. Photyx is advancing phosphorylation inducing chimeric small molecules (PHICS), a proprietary new class of bifunctional medicines that direct and repair protein phosphorylation to […]

Gingko Bioworks Exec Renee Wegrzyn to Lead New Federal Agency

Posted by ISPE Boston
On September 22, 2022

President Biden has appointed Renee Wegrzyn, PhD, as the first Director of the Advanced Research Projects Agency for Health (ARPA-H). Dr. Wegrzyn is currently the Vice President for Business Development at Ginkgo Bioworks. ARPA-H was established in March 2022 to drive transformative health breakthroughs that cannot readily be accomplished through traditional research or commercial activity. […]

Congratulations to Jim Grunwald, Hank Moes Award Winner!

Posted by ISPE Boston
On September 15, 2022

Jim Grunwald has a consistent, long-standing, and extraordinary legacy of supporting ISPE, specifically the Boston Area Chapter. As an ISPE member for over 30 years, Jim was instrumental in ushering in the modern-day version of the ISPE Boston Area Chapter, the largest and most successful chapter in ISPE. His contributions include President of the Board […]

Page 30 of 118«‹28 293031 32 ›»